General Pathology

Theme 7: Chronic Inflammation


  1. Explain the process of chronic inflammation.
  2. Explain the process of granulomatous inflammation.
  3. Identify the morphologic patterns in acute and chronic inflammation.
  4. Identify the factors that can modify the inflammatory reaction
  5. Discuss the sequelae and systemic effects of chronic and granulomatous inflammation.

Chronic inflammation can be defined as inflammation of prolonged duration (weeks or months) in which active inflammation, tissue destruction, and attempts at healing may all be proceeding simultaneously. It arises in several ways:

In contrast to acute inflammation, which is manifested by vascular changes, edema and largely neutrophilic infiltration, chronic inflammation is characterized by:

Processes of Chronic Inflammation

Chronic inflammation usually occurs in response to an injurous agent that is antigenic, e.g., a microorganism but may also develop in response to self antigens released from damaged tissues. The immune response is triggered by the first contact with the antigen but takes some days to become apparent in the tissue. Local persistence of the antigen leads to accumulation of activated T lymphocytes, plasma cells and macrophages at the site of injury. Because these cells are the prominent cell types in inflammation, effector cells of the immune response are also called chronic inflammatory cells.

Although it is triggered at the time of injury, the immune response takes several days to develop because the nonsensitized lymphocytes that initially respond to antigens must pass through several division cycles before increased numbers of effector lymphocytes become manifest in the tissues. Simple uncomplicated acute inflammation usually resolves upon removal of antigen prior to any apparent tissue manifestation of the immune response.

Macrophages (monocytes) are recruited to the lesion from the blood by such chemotactic factors as C5a and TGFß. Local activation occurs under the influence of multiple cytokines, particularly g interferon and IL-4. Macrophages in turn release a variety of factors that perpetuate the developing immune response, including cytokines (IL-1, IL-6 and TNFa), complement components, prostaglandin and various growth factors such as FGF (fibroblast growth factor), PDGF (platelet-derived growth factor) and TGFß (transforming growth factor). Multiple proteases and hydrolases contribute to the phagocytic and microbicidal effect.

Granulomatous Inflammation

Granulomatous inflammation is a distinctive chronic inflammatory reaction in which the predominant cell type is an activated macrophage with a modified epithelial-like (epithelioid) appearance. In the focus of inflammation (granuloma), microscopic aggregations of macrophages are transformed into epitheloid cells surrounded by collar of mononuclear leykocytes, principally lymphocytes and occasional plasma cells. Such epitheloid cells often fuse to form giant cells comprising of a large mass of cytoplasm with 20 or more small nuclei arranged peripherally in a horseshoe shape (Langhan's Giant Cell) or haphazardly (body-type).

Morphologic Patterns in Acute and Chronic Inflammation

Inflammatory responses often have certain features that point to their possible cause and create distinctive morphologic patterns:

Systemic Effects of Inflammation

The major systemic manifestations of acute inflammation involve a wide range of endocrine, autonomic, and behavioral responses, as follows:

Other major systemic manifestations are as follows: Thus, the major systemic effects of a significant inflammation reaction are fever, leukocytosis (most often owing to an increased number of circulating neutrophils, sometimes lymphocytes) and chills, well known to all who have had a respiratory infection.

Factors Modifying the Inflammatory Reaction

 Groups Mediators Phase Origin Effect
Amines Histamine Early phase, allergic response Mast cells Increase vascular permeability
Serotonin Early phase Platelets Increase vascular permeability
Nor/Adrenaline Not great impt.   Reduce vascular permeability
Kinins Bradykinin, Kallidin Early phase Precursor kininogens Vasodilator, pain
Plasmin Early phase Plasminogen Digests fibrin (increase vascular permeability)
Chemotactic via C3a
Kinin forming enzymes Kallikrein Early phase (produces kinins)   Vasodilator, chemotactic to WBC
Complement C3a, C5a, C567   Macrophages Release of histamine from mast cells
Vasodilator, chemotactic
Lysosomal components Cationic proteins   Neutrophil,
Polymorphs
Increase permeability, chemotactic
Acid proteases Act on kininogen to produce kinins
Neutral proteases Degrade collagen, increase permeability
Arachidonic acid derivatives Prostaglandins (PGE1/2)   Tissues, mast cells, platelets Vasodilation, increase permeability, pain
Others Lactic acid
Lymphokines
  Mast cells Vasodilation, increase permeability, chemotactic
Hosted by www.Geocities.ws

1